Abstract:Growth factor and cytokine signaling can influence the development of several cancer types. One of the key players in the development of cancer is the Janus kinas (JAK) signal transducer of activators of transcription (STAT) signaling pathway. The majority of growth factors and cytokine interactions with their membrane-bound receptors trigger JAK-STAT activation. The influential relationship between obesity and cancer is a fact. However, there is a complex sequence of events contributing to the regulation of this mechanism to promote tumor growth, yet to be fully elucidated. The JAK-STAT pathway is influenced by obesity-associated changes that have been shown to impact cancer growth and progression. This intricate process is highly regulated by a vast array of adipokines and cytokines that exert their pleiotropic effects on cancer cells to enhance metastasis to distant target sites. Leptin is a cytokine, or more precise, an adipokine secreted mainly by adipose tissue that requires JAK-STAT activation to exert its biological functions. Leptin is the central regulator of energy balance and appetite. Leptin binding to its receptor OB-R in turn activates JAK-STAT, which induces proliferation, angiogenesis, and anti-apoptotic events in normal cells and malignant cells expressing the receptor. Leptin also induces crosstalk with Notch and IL-1 (NILCO), which involves other angiogenic factors promoting tumor growth. Therefore, the existence of multiple novel classes of therapeutics that target the JAK/STAT pathway has significant clinical implications. Then, the identification of the signaling networks and factors that regulate the obesity-cancer link to which potential pharmacologic interventions can be implemented to inhibit tumor growth and metastasis. In this review, we will discuss the specific relationship between leptin-JAK-STAT signaling and cancer.

Leptin-induced signaling pathways in cancer cell migration and invasion

Leptin-Induced JAK/STAT Signaling and Cancer Growth

The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression

Leptin Promotes the Immune Escape of Lung Cancer by Inducing Proinflammatory Cytokines and Resistance to Apoptosis

Leptin Regulation of Cancer Stem Cells in Breast and Gynecologic Cancer

Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway

The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications

Obesity and leptin in breast cancer angiogenesis

Role of leptin in the pathogenesis of breast cancer

Leptin Signaling Enhances Cell Invasion and Promotes the Metastasis of Human Pancreatic Cancer Via Increasing MMP-13 Production.

Regulation of mitochondrial metabolism by autophagy supports leptin-induced cell migration

Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways

Leptin and Adiponectin: Emerging Therapeutic Targets in Breast Cancer

Unravelling the role of obesity and lipids during tumor progression

An Overview of Recent Findings that Shed Light on the Connection between Fat and Cancer

The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer

Leptin signaling and leptin resistance.

Adipokines and epithelial-mesenchymal transition (EMT) in cancer

The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors

Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet